Verbatim response from Perplexity
For most people, Zepbound is worth the extra cost because it is FDA-approved, tested in large clinical trials, and made under tighter quality controls than compounded tirzepatide.[7][8] The main reason to choose compounded tirzepatide is price, but you are trading away some certainty about safety, consistency, and regulatory oversight.[7][8]
What matters most:
- Zepbound advantages: FDA approval, consistent manufacturing, and better-known safety/effectiveness profile.[7][8]
- Compounded tirzepatide advantages: usually lower cash price, often around $150–$500/month versus Zepbound list pricing that can be around $1,049–$1,086/month or higher depending on form and source.[1][2][4]
- Compounded tirzepatide drawbacks: it is not FDA-approved, quality can vary by pharmacy, and there can be risks such as dosing errors or contamination.[7][8]
- Important 2026 practical point: at least one source says the shortage has ended and pharmacies are no longer allowed to regularly compound tirzepatide injections, which may limit access to legitimate compounded versions.[4]
A useful rule of thumb:
- Choose Zepbound if you can afford it, have insurance or a manufacturer discount, or want the most reliable option.[4][7]
- Consider compounded tirzepatide only if cost is the decisive barrier, and only through a reputable compounding pharmacy under a clinician’s supervision.[7][8]
Also, Zepbound may be less expensive than many people expect if you use the lower-cost vial or pharmacy-direct options; one source says LillyDirect offers some doses for $299–$449/month.[4][7] That makes the “brand premium” smaller than the standard retail list price in some cases.[4][7]
If you want, I can help you compare your actual monthly out-of-pocket cost for Zepbound vs compounded tirzepatide based on your dose, insurance, and pharmacy access.